Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Company announcement – No. 21 / 2025 Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Copenhagen, Denmark, September 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end o...
Nextensa sells a retail site in Ingeldorf to the Luxembourg State PRESS RELEASE NON - REGULATED INFORMATIONBrussels, 29 September 2025, 7:25 CEST Nextensa sells a retail site in Ingeldorf to the Luxembourg State Luxembourg, 29 September 2025 – Nextensa announces the sale of a real estate asset located in Ingeldorf to the State of the Grand Duchy of Luxembourg. The transaction, structured as an asset deal, represents a net amount of € 19.6 million for the seller. The retail property, part of Nextensa’s portfolio since 2008, comprises a Batiself building as well as a separate extension...
Nextensa cède un site commercial situé à Ingeldorf à l’Etat luxembourgeois COMMUNIQUÉ DE PRESSE INFORMATION NON - RÉGLEMENTÉEBruxelles, 29 septembre 2025, 07h25 Nextensa cède un site commercial situé à Ingeldorf à l’Etat luxembourgeois Luxembourg, le 29 septembre 2025 – Nextensa annonce la vente d’un actif immobilier situé à Ingeldorf à l’État du Grand-Duché de Luxembourg. La transaction, réalisée sous la forme d’un asset deal, représente un montant net de 19,6 millions d’euros pour le vendeur. L’actif commercial, intégré au portefeuille de Nextensa depuis 2008, comprend un bâtime...
Nextensa verkoopt een retail site in Ingeldorf aan de Luxemburgse Staat PERSBERICHT NIET - GEREGLEMENTEERDE INFORMATIEBrussel, 29 september 2025, 7u25 Nextensa verkoopt een retail site in Ingeldorf aan de Luxemburgse Staat Luxemburg, 29 september 2025 – Nextensa kondigt de verkoop aan van een vastgoedactief gelegen in Ingeldorf aan de Staat van het Groothertogdom Luxemburg. De transactie, die werd uitgevoerd in de vorm van een asset deal, vertegenwoordigt een netto bedrag van 19,6 miljoen euro voor de verkoper. Het retailvastgoed, sinds 2008 deel uitmakend van de portefeu...
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Press release – No. 14 / 2025 Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Copenhagen, Denmark, September 24, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced the appointment of Rachel James-Owens as Vice President, Corporate Communications & Media Relations. Rachel brings over 20 years of global...
KBC Securities will host its annual life sciences conference on 25 September in Brussels. The event will include 14 exciting companies, both public and private, from the BeNeLux ecosystem and beyond. In this conference note, we provide an overview of the attending companies, as well as an outlook on KBC Securities' life sciences broader coverage.
Past Monday, Fugro surprised the market with another profit warning. While the long-term outlook remains fundamentally positive, this new warning further undermines investor confidence, especially as the updated FY25 guidance was issued only seven weeks ago. In our view, the lack of visibility and the potential for further disappointments are balanced by attractive long-term demand dynamics, a solid balance sheet, and ongoing cost and capex reductions. As a result, we rate the stock Hold. Our ne...
Last week’s EPRA conference provided cautious optimism on listed European real estate. The segment offers a mix of risks and opportunities, with discounted valuations presenting attractive entry points. We downgrade Care Property Invest (Underperform vs Neutral, TP €12 vs €13.5); we lower our TPs for British Land, Landsec, Shurgard, and Xior Student Housing; we raise our TPs for URW, Wereldhave and VGP. In conclusion we favour logistics, retail, Spain, and CEE for growth, and Switzerland remains...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.